GLP-1 sellers that name their pharmacy
Only sellers that name their compounding pharmacy.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
4 sellers are partners on this board today, sorted first and labeled Partner — the one respect in which the ordering is commercial. Every other seller here is ranked purely on the published rubric, which cannot see commercial status either way.
The board at a glance
- 6 sellers are on the named-pharmacy GLP-1 board; 6 of them name their compounding pharmacy, and 2 require a consultation before any prescription.
- The lowest monthly figure published in this board's scope is $189/mo, for Semaglutide injection at PlexusDx; price is 6% of the order here, so it does not decide the rank.
What the evidence says, before the sellers
- SemaglutideFDA-approved
Large trials for weight. 1 randomized trial of 1,000 or more people cited here for weight.
Every trial above used the approved product at labeled doses. None tested a compounded preparation, so their results describe Wegovy, not what a compounding pharmacy makes.
- TirzepatideFDA-approved
Large trials for weight. 1 randomized trial of 1,000 or more people cited here for weight.
Both trials used the approved product. Neither tested a compounded preparation, so the numbers describe Zepbound, not a pharmacy's version of it.
The ranking
Each seller below prescribes semaglutide and tirzepatide and has a full review on this site; each block reads its care mark by mark, in the words its own pages support.
- Rank01
Synergy RxPartner
Synergy Rx is first on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Semaglutide oral (compounded)from $299/mo
- Tirzepatide injection (compounded)from $349/mo
- Tirzepatide oral (compounded)from $399/mo
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: schedule printed, no strength; Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Synergy Rx is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank02
OakPartner
Oak is second on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $200/mo
- Tirzepatide injection (compounded)from $250/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Price rises with the dose
On the named-pharmacy GLP-1 board Oak is read on 70% of the rubric's weight: follow-up and state coverage are left out of its order, not counted against it.
- Rank03
Breeze MedsPartner
Breeze Meds is third on the named-pharmacy GLP-1 board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Semaglutide oral (compounded)from $299/mo
- Tirzepatide injection (compounded)price not published
- Tirzepatide oral (compounded)from $399/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: no dose printed; Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board Breeze Meds is read on 70% of the rubric's weight: follow-up and price as the dose rises are left out of its order, not counted against it.
- Rank04
Care Bare RxPartner
Care Bare Rx is fourth on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price as the dose rises.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the named-pharmacy GLP-1 board Care Bare Rx is read on 65% of the rubric's weight: dosing guidance and follow-up are left out of its order, not counted against it.
- Rank05
PlexusDx
PlexusDx is fifth on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Semaglutide injection (compounded)from $189/mo
- Tirzepatide injection (compounded)from $289/mo
- Semaglutide oral (compounded)from $289/mo
- Tirzepatide oral (compounded)from $349/mo
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Semaglutide: strength and schedule printed; Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board PlexusDx is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank06
EdgeRx
EdgeRx is sixth on the named-pharmacy GLP-1 board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Semaglutide injection (compounded)from $199/mo
- Tirzepatide injection (compounded)from $225/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 46 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the named-pharmacy GLP-1 board EdgeRx is read on 70% of the rubric's weight: dosing guidance and price as the dose rises are left out of its order, not counted against it.
What the order on this board weighs
On the named-pharmacy GLP-1 board 8 of the rubric's 9 marks apply, rescaled to share the whole order between them: prescriber and intake carries 29%, pharmacy named carries 18% and dosing guidance carries 12%. What each mark reads
- 29%
- Prescriber and intake
- 18%
- Pharmacy named
- 12%
- Dosing guidance
- 12%
- Follow-up
- 12%
- Stays within legal scope
- 6%
- State coverage
- 6%
- Price against the market
- 6%
- Price as the dose rises
Whether a seller pays us is not one of the 8 marks on the named-pharmacy GLP-1 board, and the rubric cannot read it.
GLP-1 sellers that name their pharmacy
Frequently asked questions
- How is the named-pharmacy GLP-1 board ordered?
- The 4 partners sort first and are labeled; after that the rubric decides. The rubric reads each seller on semaglutide and tirzepatide, and here prescriber and intake carries 29%, pharmacy named carries 18% and dosing guidance carries 12%.
- Do you earn a commission from the sellers on the named-pharmacy GLP-1 board?
- On part of it. 4 sellers are partners on the named-pharmacy GLP-1 board, labeled Partner where they appear; the rest of the links pay us nothing.
- Which marks are not recorded on the named-pharmacy GLP-1 board?
- Not recorded: price as the dose rises for Synergy Rx, follow-up and state coverage for Oak, follow-up and price as the dose rises for Breeze Meds, dosing guidance and follow-up for Care Bare Rx, price as the dose rises for PlexusDx and dosing guidance and price as the dose rises for EdgeRx. Each is left out of that seller's order on this board, because our review of its pages found no answer, and the seller's other marks carry its place instead.
- Which sellers of semaglutide and tirzepatide are not on this board?
- 392 more sellers on our roster publish a price for semaglutide and tirzepatide and are not ranked on the named-pharmacy GLP-1 board until we publish a review of each one.